# Safety Study of Single Administration Intravenous Treatment for Influenza

> **NCT01375985** · PHASE1 · TERMINATED · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AVI-7100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01375985
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The study was halted after enrollment of the first cohort because of lack of funding
- **Last updated:** 2013-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375985, "Safety Study of Single Administration Intravenous Treatment for Influenza". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01375985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*